Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy.

Literature DB >> 2764407

Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy.

J S Adams¹, M M Diz, O P Sharma.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Chloroquine
Calcitriol

Year: 1989 PMID： 2764407 DOI： 10.7326/0003-4819-111-5-437

Source DB: PubMed Journal: Ann Intern Med ISSN： 0003-4819 Impact factor: 25.391

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors: M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal: Gut Date: 2004-08 Impact factor: 23.059

Review 2. Clinical impact of bone and calcium metabolism changes in sarcoidosis.

Authors: G Rizzato
Journal: Thorax Date: 1998-05 Impact factor: 9.139

3. Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.

Authors: J Jacobs; L-A Korswagen; A M Schilder; L H van Tuyl; B A C Dijkmans; W F Lems; A E Voskuyl; I E M Bultink
Journal: Osteoporos Int Date: 2012-10-03 Impact factor: 4.507

Review 4. Bone health issues in sarcoidosis.

Authors: Nadera J Sweiss; Elyse E Lower; Peter Korsten; Timothy B Niewold; Murray J Favus; Robert P Baughman
Journal: Curr Rheumatol Rep Date: 2011-06 Impact factor: 4.592

Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy.

1. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Review 2. Clinical impact of bone and calcium metabolism changes in sarcoidosis.

3. Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.

Review 4. Bone health issues in sarcoidosis.

Review 5. Extrapulmonary manifestations of sarcoidosis.

6. Hypercalcemia associated with dysregulation of 1,25-dihydroxyvitamin D in arthritis.

Review 7. Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.

8. Hyercalcemia induced by interferon therapy in chronic hepatitis C.

9. SILICONE GRANULOMATOUS INFLAMMATION RESULTING IN HYPERCALCEMIA: A REVIEW OF THE LITERATURE.

Review 10. Current and emerging pharmacological treatments for sarcoidosis: a review.